Subcutaneous formulation of RoActemra launched

Patients with moderate to severe active rheumatoid arthritis (RA) can now self-administer RoActemra (tocilizumab), following the launch of a prefilled syringe for subcutaneous injection.

After proper training, patients with rheumatoid arthritis (pictured) may self-inject RoActemra if deemed appropriate | SCIENCE PHOTO LIBRARY
After proper training, patients with rheumatoid arthritis (pictured) may self-inject RoActemra if deemed appropriate | SCIENCE PHOTO LIBRARY

Tocilizumab is the only interleukin-6 receptor antagonist available for both subcutaneous and intravenous administration in RA. The 162mg prefilled syringe for subcutaneous administration can be used both as monotherapy and in combination with methotrexate or other DMARDs.

"The versatility that RoActemra now offers is extremely valuable to the patient, not to mention the freeing up of precious consulting time for clinicians," said Professor Choy, Professor of Rheumatology at the Cardiff Institute of Infection & Immunity.

The SUMMACTA study showed that the efficacy of subcutaneous tocilizumab was comparable to that of the intravenous formulation. The adverse event profiles of the subcutaneous and intravenous formulations were also comparable, with the exception of a higher incidence of injection site reactions observed with the subcutaneous injection.

View RoActemra drug record

Further information: Roche 

Follow MIMS on Twitter

Sign up for MIMS bulletins


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.